SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-025334
Filing Date
2018-10-29
Accepted
2018-10-29 08:45:18
Documents
3
Period of Report
2018-10-29
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acer-8k_20181026.htm 8-K 28520
2 EX-99.1 acer-ex991_6.htm EX-99.1 16694
3 GRAPHIC glpsqhyi4aw1000001.jpg GRAPHIC 4064
  Complete submission text file 0001564590-18-025334.txt   52404
Mailing Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458
Business Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458 (844) 902-6100
Acer Therapeutics Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 320426967 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33004 | Film No.: 181142882
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1